175 related articles for article (PubMed ID: 38453924)
21. In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis.
Heitink L; Whittle JR; Vaillant F; Capaldo BD; Dekkers JF; Dawson CA; Milevskiy MJG; Surgenor E; Tsai M; Chen HR; Christie M; Chen Y; Smyth GK; Herold MJ; Strasser A; Lindeman GJ; Visvader JE
Mol Oncol; 2022 Mar; 16(5):1119-1131. PubMed ID: 35000262
[TBL] [Abstract][Full Text] [Related]
22. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3.
Batır MB; Şahin E; Çam FS
Mol Biol Rep; 2019 Dec; 46(6):6471-6484. PubMed ID: 31571107
[TBL] [Abstract][Full Text] [Related]
24. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
25. Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9.
Guo T; Chen GQ; Li XF; Wang M; Liu KM; Yang XY; Liu SC; Feng YL; Liu PY; Lin H; Xie AY
Genome Med; 2023 Oct; 15(1):80. PubMed ID: 37803452
[TBL] [Abstract][Full Text] [Related]
26. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
27. A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13.
Luo Z; Rhie SK; Lay FD; Farnham PJ
Cell Rep; 2017 Nov; 21(6):1411-1417. PubMed ID: 29117547
[TBL] [Abstract][Full Text] [Related]
28. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
[TBL] [Abstract][Full Text] [Related]
29. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
Gururajan M; Josson S; Chu GC; Lu CL; Lu YT; Haga CL; Zhau HE; Liu C; Lichterman J; Duan P; Posadas EM; Chung LW
Clin Cancer Res; 2014 Dec; 20(24):6559-69. PubMed ID: 25324143
[TBL] [Abstract][Full Text] [Related]
30. Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer.
Barquilha CN; Santos NJ; Monção CCD; Barbosa IC; Lima FO; Justulin LA; Pértega-Gomes N; Felisbino SL
Oxid Med Cell Longev; 2020; 2020():2148562. PubMed ID: 32411320
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide CRISPR/Cas9 knockout screening uncovers ZNF319 as a novel tumor suppressor critical for breast cancer metastasis.
Wang L; Zhou L; Li M; Zhao J; Liu Y; Chen Y; Qin X; Wang S; Chen H; Piao Y; Xiang R; Li J; Shi Y
Biochem Biophys Res Commun; 2022 Jan; 589():107-115. PubMed ID: 34902746
[TBL] [Abstract][Full Text] [Related]
32. Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer.
Kumar Mamidi TK; Wu J; Hicks C
Biomed Res Int; 2021; 2021():6641429. PubMed ID: 33511206
[TBL] [Abstract][Full Text] [Related]
33. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
[TBL] [Abstract][Full Text] [Related]
34. Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice.
Park JJ; Kim JE; Jeon Y; Lee MR; Choi JY; Song BR; Park JW; Kang MJ; Choi HJ; Bae SJ; Lee H; Kang BC; Hwang DY
Technol Cancer Res Treat; 2020; 19():1533033820964425. PubMed ID: 33094683
[TBL] [Abstract][Full Text] [Related]
35. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
[TBL] [Abstract][Full Text] [Related]
36. Cabs1 Maintains Structural Integrity of Mouse Sperm Flagella during Epididymal Transit of Sperm.
Zhang X; Zhou W; Zhang P; Gao F; Zhao X; Shum WW; Zeng X
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440775
[TBL] [Abstract][Full Text] [Related]
37. The Disruption of Mage-11 Gene via CRISPR/Cas9 Method Induced Apoptosis in the in vitro Model of Prostate Cancer.
Farhadi L; Soleimani F; Fakhari S; Jalili A
Gulf J Oncolog; 2023 Jan; 1(41):7-16. PubMed ID: 36804154
[TBL] [Abstract][Full Text] [Related]
38. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in Prostate Cancer Growth and Metastasis.
Xiao C; Liang W
Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
[TBL] [Abstract][Full Text] [Related]
39. In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer.
Rushworth LK; Harle V; Repiscak P; Clark W; Shaw R; Hall H; Bushell M; Leung HY; Patel R
Life Sci Alliance; 2020 Dec; 3(12):. PubMed ID: 33033111
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects.
Frank S; Nelson P; Vasioukhin V
F1000Res; 2018; 7():. PubMed ID: 30135717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]